Advertisement

Topics

Companies Related to "Esperance Pharmaceuticals Product Pipeline Review 2015" [Most Relevant Company Matches] RSS

00:21 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Esperance Pharmaceuticals Product Pipeline Review 2015" found in our extensive corporate database of over 50,000 company records.

Showing "Esperance Pharmaceuticals Product Pipeline Review 2015" Companies 1–25 of 6,500+

Relevant

Esperance Pharmaceuticals, Inc.

Esperance Pharmaceuticals, Inc. is developing a new class of targeted anticancer drugs using its Cationic Lytic Peptide (CLYP(TM)) platform technology. These drug candidates, called targeted membrane-disrupting peptides (tMDPs) and antibody drug conjugates (ADCs), selectively kill cancer cells, including cells known to be resistant to chemotherapeutic drugs, without harming normal cells. Targeting...


Millennium Pharmaceuticals, Inc.

Millennium Pharmaceuticals, The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the h...

Expert Opinion

The Expert Opinion series of review journals provides systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs.


Pro-Pharmaceuticals, Inc.

Pro-Pharmaceuticals, OTCBB: PRWP, is the leader in the field of Galectin therapeutics and is engaged in the discovery, development and commercialization of therapeutics that target Galectin receptors for advanced treatment of cancer and fibrosis. Initially, the product pipeline is focused on increasing the efficacy and decreasing the toxicity of chemothera...

Aspen Park Pharmaceuticals, Inc.

Founded in 2014, Aspen Park Pharmaceuticals, Inc. is a privately held therapeutics company that focuses on the development of men’s health therapies for important medical diseases and conditions. The men’s health therapeutics market is estimated to be $10 billion worldwide. Two urologists, Dr. Harry Fisch and Dr. Mitchell Steiner, cofounded the c...

Informa Healthcare - Expert Opinion series

The Expert Opinion series of review journals provides systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs

Trubion Pharmaceuticals, Inc.

Trubion is a biopharmaceutical company that is creating a pipeline of novel protein therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. The Company's mission is to develop a variety of first-in-class and best-in-class product candidates, customized for optimal safety, efficacy and convenience that it believes may offer improved patient experiences. Trubion's cu...

Trubion Pharmaceuticals Inc.

Trubion is a biopharmaceutical company that is creating a pipeline of novel protein therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. The Company's mission is to develop a variety of first-in-class and best-in-class product candidates, customized for optimal safety, efficacy and convenience that it believes may offer improved patient experiences. Trubion's cu...

Amneal Pharmaceuticals, LLC

Amneal Pharmaceuticals, LLC, with principal offices in Bridgewater, NJ, is a U.S.-based firm that develops, manufactures and distributes generic pharmaceuticals regulated and approved by the U.S. FDA. Known as “Generic’s New Generation,” the company utilizes its newly expanded R&D and manufacturing capabilities to conceive breakthrough developments...

Indevus Pharmaceuticals

We acquire, develop and commercialize products for multiple therapeutic areas, with a primary commitment to urology, gynecology and men's health. Our robust clinical-stage pipeline has the potential to improve the quality of life for millions of patients. We are focused on individual compounds, rather than on earlier stage, relatively unproven drug discovery technologies. We continually seek produ...

Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. Spectrum currently markets six hematology/oncology drugs and has an advanced stage pipeline that has the potential to transform the company. Spectrum's strong track record for in-l...

Alpha Review Corporation

Alpha Review Corporation (ARC) was formed in 1995 as a medical bill review company. ARC customizes its bill review services to meet the client's individual needs by setting specific and unique customer notification parameters, providing customized management reports, and meeting any number of perhaps seemingly minor, but critical needs. This ensures a smoo...

SciClone Pharmaceuticals, Inc.

SciClone Pharmaceuticals (NASDAQ: SCLN) is a profit-driven, global specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. SciClone is focused on continuing international sales growth, a cost-containing clinical development strategy, and overall expense manage...

Harvard Business Review

Harvard Business Review is the leading destination for smart management thinking. Through its flagship magazine, 12 international licensed editions, books from Harvard Business Review Press, and digital content and tools published on HBR.org, Harvard Business Review provides professionals around the world with rigorous insights and best practic...

Technology Review

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Technology Review, Inc.

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Maxim Pharmaceuticals Incorporated

Maxim Pharmaceuticals, Inc. is a global biopharmaceutical company with a strong pipeline of product candidates addressing cancer, hepatitis and other liver diseases. To date, Maxim has generated a significant body of clinical evidence supporting the Company’s multiple product candidates. Maxim’s research and development programs offer hope to patients by developing safe and effective therape...

Cylene Pharmaceuticals

Cylene Pharmaceuticals is a privately-held pharmaceutical company dedicated to the discovery, development and commercialization of first-in-class small molecule drugs to treat life-threatening cancers. Cylene's pipeline is led by CX-3543, a Quadruplex Inhibitor in Phase 1 clinical development. CX-3543 and other molecules in the pipeline originate from the company's proprietary drug discovery platf...

Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals, Inc. is an acute care specialty pharmaceutical company founded in March, 2007 through the acquisition of the former SkyePharma PLC injectable business, for which an experienced management team was assembled to address the needs of the acute care market. The company's most advanced product, EXPAREL(TM) (DepoBupivacaine), a bupivacaine-based product intended to deliver post o...

Vertex Pharmaceuticals Inc.

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989, Vertex today employs more than 2,000 people at sites around the world.  In addition to our headquarters in Massachusetts, Vertex has research and development sites and other offices in San Diego, CA; Abingd...

PureTech Health

PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary healthcare company, developing innovative products that could improve the lives of billions of patients. PureTech has a pipeline of 12 operating companies, seven of which are "growth stage" with external validation including strategic partnerships, outside funding, proof-of-concep...

Symplmed Pharmaceuticals

Symplmed Pharmaceuticals is a private pharmaceutical company optimizing the value of its medicines and those of its industry partners by streamlining the prescription process, from fulfillment and payment to therapeutic compliance and outcomes monitoring. The Company’s patented technology platform, DyrctAxess, enables direct delivery of medications to...

Titan Pharmaceuticals

Titan Pharmaceuticals, Inc. (AMEX: TTP)is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders. Titan's products in development utilize novel technologies that have the potential to significantly improve the treatment of these diseases. Titan also establishes p...

Merrimack Pharmaceuticals,Inc.

Merrimack Pharmaceuticals, Inc. is a privately held biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer. Our goal is to provide patients and physicians with not only the best possible treatments, but to support our pharmaceuticals with the tools to enable the prescrip...

IDEC Pharmaceuticals Corporation

IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, developmentand commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. IDEC Pharmaceuticals first commercial product, Rituxan, and their most advanced product candidate, IDEC-Y2B8, are for use in the treatment of certain B-cell NHLs. IDEC Pharmace...


More From BioPortfolio on "Esperance Pharmaceuticals Product Pipeline Review 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks